Significant Ownership of STEMPOINT CAPITAL LP
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for STEMPOINT CAPITAL LP focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Sean C. Tan - Sean C. Tan, Authorized Signatory
- Manager location
- New York, NY
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow STEMPOINT CAPITAL LP and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from STEMPOINT CAPITAL LP
Significant Ownership of STEMPOINT CAPITAL LP
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| SNSE | Sensei Biotherapeutics, Inc. | Common Stock, $0.0001 par value per share | 9.9% | $4,006,121 | 132,873 | StemPoint Capital LP | 31 Mar 2026 | ||
| XLO | Xilio Therapeutics, Inc. | Common stock, par value $0.0001 per share | 8.4% | $3,979,818 | +$1,339,818 | 6,030,028 | +51% | StemPoint Capital LP | 31 Dec 2025 |
| SRZN | Surrozen, Inc. | Common Stock, $0.0001 par value per share | 4.5% | $15,695,581 | -$2,810,632 | 525,639 | -15% | StemPoint Capital LP | 31 Mar 2026 |
| VTGN | Vistagen Therapeutics, Inc. | Common Stock, par value $0.001 per share | 1.5% | $456,394 | -$1,266,690 | 616,749 | -74% | StemPoint Capital LP | 31 Dec 2025 |
Schedules 13D/G Reported by STEMPOINT CAPITAL LP:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.